Olema Pharmaceuticals, Inc. (OLMA)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $291k
- Jul 24 · Unusual
- Form 4 sales
- 65
- On record
- Form 144 notices
- 97
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 144 noticeNoticeMar 9, 2026 2026
Filed to sell 241,999 shares ($3.3M)
Kovacs Shane William Charles, Former Officer
No 10b5-1 planFiling
- 2 Form 144 noticeNoticeMar 10, 2026 +1 day
Filed to sell 53,206 shares ($905k)
Kovacs Shane William Charles, Former Officer
No 10b5-1 planFiling
- 3 Form 144 noticeNoticeMar 11, 2026 +1 day
Filed to sell 50,000 shares ($797k)
Kovacs Shane William Charles, Former Officer
No 10b5-1 planFiling
- 4 Form 144 noticeNoticeMar 16, 2026 +5 days
Filed to sell 100,000 shares ($1.6M)
Kovacs Shane William Charles, Former Officer
No 10b5-1 planFiling
- 5 Form 144 noticeNoticeMar 16, 2026 same day
Filed to sell 4,166 shares ($69k)
Kovacs Shane William Charles, Former Officer
No 10b5-1 planFiling
- 6 Form 144 noticeNoticeJul 23, 2026 +129 days
Filed to sell 12,500 shares ($145k)
Harmon Cyrus, Director
No 10b5-1 plan1.7x usual sizeFiling
- 7 Form 144 noticeNoticeJul 24, 2026 +1 day
Filed to sell 12,500 shares ($146k)
Harmon Cyrus, Director
No 10b5-1 plan1.7x usual sizeFiling
- 8 Form 4 saleUnusualJul 24, 2026 same day
Sold 25,000 shares at $11.65 ($291k)
Harmon Cyrus, Director
No 10b5-1 planSold 3.4% of holdings ($8.5M position)702,770 shares left3.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales, notices and lockups (162)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Jul 27, 2026 | Harmon Cyrus | OLMA | Director | Form 4 sale | 25,000 | $291k | 3.4% | Unusual | SEC |
| Jul 24, 2026 | Jul 24, 2026 | Harmon Cyrus | OLMA | Director | Form 144 notice | 12,500 | $146k | Notice | SEC | |
| Jul 23, 2026 | Jul 23, 2026 | Harmon Cyrus | OLMA | Director | Form 144 notice | 12,500 | $145k | Notice | SEC | |
| Mar 16, 2026 | Mar 16, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 4,166 | $69k | Notice | SEC | |
| Mar 16, 2026 | Mar 16, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 100,000 | $1.6M | Notice | SEC | |
| Mar 11, 2026 | Mar 11, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 50,000 | $797k | Notice | SEC | |
| Mar 10, 2026 | Mar 10, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 53,206 | $905k | Notice | SEC | |
| Mar 9, 2026 | Mar 9, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 241,999 | $3.3M | Notice | SEC | |
| Mar 4, 2026 | Mar 5, 2026 | Mitchell Shawnte | OLMA | CHIEF LEGAL OFFICER | Form 4 sale | 40,000 | $952k | 100.0% | Unusual | SEC |
| Mar 4, 2026 | Mar 4, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 20,000 | $489k | Notice | SEC | |
| Mar 4, 2026 | Mar 4, 2026 | Mitchell Shawnte | OLMA | Officer | Form 144 notice | 25,000 | $599k | Notice | SEC | |
| Mar 3, 2026 | Mar 3, 2026 | Mitchell Shawnte | OLMA | Officer | Form 144 notice | 15,000 | $345k | Notice | SEC | |
| Feb 27, 2026 | Feb 27, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 6,521 | $163k | Notice | SEC | |
| Feb 24, 2026 | Feb 24, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 20,000 | $500k | Notice | SEC | |
| Feb 23, 2026 | Feb 23, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 10,000 | $243k | Notice | SEC | |
| Feb 23, 2026 | Feb 23, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 20,000 | $480k | Notice | SEC | |
| Feb 12, 2026 | Feb 12, 2026 | Kovacs Shane William Charles | OLMA | Former Officer | Form 144 notice | 10,000 | $238k | Notice | SEC | |
| Jan 20, 2026 | Jan 21, 2026 | Harmon Cyrus | OLMA | Director | Form 4 sale | 10,000 | $269k | 1.4% | No plan | SEC |
| Jan 20, 2026 | Jan 20, 2026 | Harmon Cyrus | OLMA | Director | Form 144 notice | 10,000 | $269k | Notice | SEC | |
| Jan 15, 2026 | Jan 15, 2026 | Kovacs Shane William Charles | OLMA | Officer | Form 144 notice | 100,000 | $2.9M | Notice | SEC | |
| Jan 15, 2026 | Jan 15, 2026 | Kovacs Shane William Charles | OLMA | CH. OPERATING & FINANCIAL OFF. | Form 4 sale | 103,822 | $3M | 42.6% | Unusual | SEC |
| Jan 14, 2026 | Jan 16, 2026 | Harmon Cyrus | OLMA | Director | Form 4 sale | 3,489 | $102k | 0.5% | No plan | SEC |
| Jan 14, 2026 | Jan 14, 2026 | Harmon Cyrus | OLMA | Director | Form 144 notice | 3,489 | $102k | Notice | SEC | |
| Jan 14, 2026 | Jan 14, 2026 | Myles David C. | OLMA | Officer | Form 144 notice | 50,000 | $1.4M | Notice | SEC | |
| Jan 14, 2026 | Jan 14, 2026 | Myles David C. | OLMA | CH. DISCOV. & NON-CLIN DEV OFF | Form 4 sale | 110,000 | $3.1M | 43.2% | Unusual | SEC |
| Jan 13, 2026 | Jan 13, 2026 | Kovacs Shane William Charles | OLMA | Officer | Form 144 notice | 3,822 | $107k | Notice | SEC | |
| Jan 13, 2026 | Jan 13, 2026 | Myles David C. | OLMA | Officer | Form 144 notice | 50,000 | $1.4M | Notice | SEC | |
| Jan 12, 2026 | Jan 12, 2026 | Myles David C. | OLMA | Officer | Form 144 notice | 10,000 | $283k | Notice | SEC | |
| Dec 23, 2025 | Dec 23, 2025 | Zojwalla Naseem | OLMA | Chief Medical Officer | Form 4 sale | 269,509 | $7.5M | 98.4% | Unusual | SEC |
| Dec 23, 2025 | Dec 23, 2025 | Zojwalla Naseem | OLMA | Officer | Form 144 notice | 99,509 | $2.8M | Notice | SEC | |
| Dec 22, 2025 | Dec 29, 2025 | Harmon Cyrus | OLMA | Director | Form 4 sale | 2,881 | $82k | 0.4% | No plan | SEC |
| Dec 22, 2025 | Dec 22, 2025 | Harmon Cyrus | OLMA | Officer | Form 144 notice | 2,881 | $82k | Notice | SEC | |
| Dec 22, 2025 | Dec 22, 2025 | Zojwalla Naseem | OLMA | Officer | Form 144 notice | 100,000 | $2.8M | Notice | SEC | |
| Dec 19, 2025 | Dec 23, 2025 | Myles David C. | OLMA | CH. DISCOV. & NON-CLIN DEV OFF | Form 4 sale | 51,000 | $1.6M | 8.5% | No plan | SEC |
| Dec 19, 2025 | Dec 23, 2025 | Clark Ian T | OLMA | Director | Form 4 sale | 264,800 | $7.9M | 100.0% | Unusual | SEC |
| Dec 19, 2025 | Dec 19, 2025 | Myles David C. | OLMA | Officer | Form 144 notice | 51,000 | $1.6M | Notice | SEC | |
| Dec 19, 2025 | Dec 19, 2025 | Zojwalla Naseem | OLMA | Officer | Form 144 notice | 70,000 | $2M | Notice | SEC | |
| Dec 19, 2025 | Dec 19, 2025 | Clark Ian T | OLMA | Director | Form 144 notice | 264,800 | $7.9M | Notice | SEC | |
| Sep 18, 2025 | Sep 18, 2025 | Harmon Cyrus | OLMA | Director | Form 4 sale | 25,000 | $205k | 3.3% | No plan | SEC |
| Sep 18, 2025 | Sep 18, 2025 | Harmon Cyrus | OLMA | Director | Form 144 notice | 13,086 | $109k | Notice | SEC | |
| Sep 16, 2025 | Sep 16, 2025 | Harmon Cyrus | OLMA | Director | Form 144 notice | 11,914 | $96k | Notice | SEC | |
| Dec 17, 2024 | Dec 17, 2024 | Graham G. Walmsley | OLMA | Director | Form 4 sale | 700,761 | $4.7M | 100.0% | Unusual | SEC |
| Dec 13, 2024 | Dec 13, 2024 | Logos Opportunities Fund I LP | OLMA | Affiliate | Form 144 notice | 700,761 | $4.7M | Notice | SEC | |
| Dec 11, 2024 | Dec 11, 2024 | Harmon Cyrus | OLMA | Director | Form 4 sale | 16,393 | $148k | 2.1% | No plan | SEC |
| Dec 11, 2024 | Dec 11, 2024 | Myles David C. | OLMA | CH. DISCOV. & NON-CLIN DEV OFF | Form 4 sale | 26,066 | $235k | 4.2% | No plan | SEC |
| Dec 11, 2024 | Dec 11, 2024 | Zojwalla Naseem | OLMA | CHIEF MEDICAL OFFICER | Form 4 sale | 27,805 | $250k | 19.4% | No plan | SEC |
| Dec 11, 2024 | Dec 11, 2024 | Kovacs Shane William Charles | OLMA | CH. OPERATING & FINANCIAL OFF. | Form 4 sale | 35,159 | $317k | 6.1% | No plan | SEC |
| Dec 11, 2024 | Dec 11, 2024 | Bohen Sean | OLMA | PRESIDENT AND CEO | Form 4 sale | 109,502 | $986k | 31.2% | Unusual | SEC |
| Dec 11, 2024 | Dec 11, 2024 | Harmon Cyrus | OLMA | Director | Form 144 notice | 8,137 | $71k | Notice | SEC | |
| Dec 11, 2024 | Dec 11, 2024 | Kovacs Shane William Charles | OLMA | Officer | Form 144 notice | 18,356 | $159k | Notice | SEC |